Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest
NCT03149406 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 245
Last updated 2018-08-03
Summary
Carotid stenosis of atherosclerotic origin may be responsible for stroke, which is one of the most important causes of morbidity and mortality in the Western world
Conditions
- miRNAs
- Carotid Plaque
Interventions
- OTHER
-
Comparing the expression of miRNAs
by PCR, in symptomatic and asymptomatic carotid plaques.
Sponsors & Collaborators
-
Centre Hospitalier Universitaire, Amiens
lead OTHER
Principal Investigators
-
Thierry REIX, PhD · CHU AMIENS-PICARDIE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-26
- Primary Completion
- 2020-12-26
- Completion
- 2020-12-26
Countries
- France
Study Locations
More Related Trials
-
Efficacy and Safety of Pactimibe in Patients With Atherosclerosis
NCT00185146 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Mechanisms and Carotid Atherosclerosis
NCT03962686 ·Status: COMPLETED
-
Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation
NCT02378064 ·Status: COMPLETED ·Phase: PHASE4
-
A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.
NCT05984537 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy
NCT00401921 ·Status: WITHDRAWN ·Phase: PHASE2
-
Carotid Plaque Regression With Statin Treatment Assessed by High Field Magnetic Resonance Imaging (MRI)
NCT00388843 ·Status: WITHDRAWN
-
Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis
NCT02124928 ·Status: UNKNOWN
-
Prospective Carotid Artery Stenosis Trial
NCT05724836 ·Status: RECRUITING
-
Cardiovascular Inflammation Reduction Trial
NCT01594333 ·Status: COMPLETED ·Phase: PHASE3
-
Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.
NCT00307307 ·Status: COMPLETED ·Phase: PHASE4
-
The Changes in Carotid Plaque Neovascularization After Elovocumab Therapy
NCT04423406 ·Status: UNKNOWN
-
Effect of Evolocumab on Coronary Atherosclerosis
NCT03689946 ·Status: COMPLETED ·Phase: PHASE3
-
Atherosclerosis in the Coronary and Carotid Arteries
NCT00080587 ·Status: COMPLETED
-
Identification of Biomarkers in Subjects With Coronary Syndrome (PLAQUE Study)
NCT06103357 ·Status: RECRUITING
-
Bacteria in Atherosclerotic Plaques and Adverse Events
NCT06935279 ·Status: COMPLETED
-
Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)
NCT01718288 ·Status: COMPLETED ·Phase: PHASE4
-
Carotid Plaque Screening Trial in Smokers
NCT00548665 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients
NCT00751608 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)
NCT02956993 ·Status: COMPLETED ·Phase: PHASE1
-
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
NCT01178320 ·Status: COMPLETED
-
Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED)
NCT00384293 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Feasibility Study of the Shockwave Lithoplasty System
NCT01577888 ·Status: COMPLETED ·Phase: NA
-
Revacept in Symptomatic Carotid Stenosis
NCT01645306 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
NCT03872401 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
NCT01059682 ·Status: TERMINATED ·Phase: PHASE3